These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3121470)

  • 21. The effects of dermatan sulfate at submicrogram/ml concentrations on in vitro thrombin generation.
    Delorme MA; Tam AS; Xu L
    Thromb Haemost; 1996 May; 75(5):747-51. PubMed ID: 8725717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The endothelium, platelets, and brain ischemia.
    Caplan LR; Fisher M
    Rev Neurol Dis; 2007; 4(3):113-21. PubMed ID: 17943063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical experience with a new antithrombotic (dermatan sulfate) in chronic hemodialysis patients.
    Nurmohamed MT; Knipscheer HC; Stevens P; Krediet RT; Roggekamp MC; Berckmans RJ; ten Cate JW
    Clin Nephrol; 1993 Mar; 39(3):166-71. PubMed ID: 8462205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dermatan sulfate in pharmaceutical heparins.
    Perlin AS; Sauriol F; Cooper B; Folkman J
    Thromb Haemost; 1987 Aug; 58(2):792. PubMed ID: 3672433
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of acetaldehyde-glycosaminoglycan mixtures upon Factor IXa and Factor IX-Deficient Plasma.
    Brecher AS; Moon AR; Gray KD
    Alcohol; 2006 Jun; 39(2):97-104. PubMed ID: 17134662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of thrombin inhibition by heparin cofactor II and antithrombin in the presence of the ray (Raja radula) skin dermatan sulfate.
    Ben Mansour M; Dhahri M; Vénisse L; Jandrot-Perrus M; Chaubet F; Maaroufi RM
    Thromb Res; 2009 Apr; 123(6):902-8. PubMed ID: 19046760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of glycosaminoglycans on coagulation: a thromboelastographic study.
    Senzolo M; Coppell J; Cholongitas E; Riddell A; Triantos CK; Perry D; Burroughs AK
    Blood Coagul Fibrinolysis; 2007 Apr; 18(3):227-36. PubMed ID: 17413758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological profile of a native dermatan sulfate.
    Santoro FM; Alvarez R; Fussi F
    Thromb Res; 1992 Jul; 67(2):201-11. PubMed ID: 1440522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of cultured bovine aortic endothelial cell proliferation by sodium spirulan, a new sulfated polysaccharide isolated from Spirulina platensis.
    Kaji T; Fujiwara Y; Hamada C; Yamamoto C; Shimada S; Lee JB; Hayashi T
    Planta Med; 2002 Jun; 68(6):505-9. PubMed ID: 12094292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of flavonoids on blood-vessel wall interactions.
    Beretz A; Cazenave JP
    Prog Clin Biol Res; 1988; 280():187-200. PubMed ID: 3051026
    [No Abstract]   [Full Text] [Related]  

  • 31. A small fraction of dermatan sulfate with significantly increased anticoagulant activity was selected by interaction with the first complement protein.
    Calabrese GC; Alberto MF; Tubio R; Marani MM; Fernández De Recondo ME; Lazzari M; Recondo EF
    Thromb Res; 2004; 113(3-4):243-50. PubMed ID: 15140589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural composition and anticoagulant activity of dermatan sulfate from the skin of the electric eel, Electrophorus electricus (L.).
    Souza ML; Dellias JM; Melo FR; Silva LC
    Comp Biochem Physiol B Biochem Mol Biol; 2007 Jul; 147(3):387-94. PubMed ID: 17360213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.
    Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G
    Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential action of sulfated glycosaminoglycans on follicle-stimulating hormone-induced functions of cumuli oophori isolated from mice.
    Eppig JJ; Ward-Bailey PF; Potter JE; Schultz RM
    Biol Reprod; 1982 Sep; 27(2):399-406. PubMed ID: 6289927
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacology of a new low molecular weight dermatan sulphate (Desmin) in healthy volunteers: repeated daily intramuscular administration of 400 mg for a week.
    Dettori AG; Zamboni V; Manotti C; Canova N; Barbanti M; Palazzini E
    Thromb Res; 1996 Jul; 83(1):103-9. PubMed ID: 8837309
    [No Abstract]   [Full Text] [Related]  

  • 36. Controlling cancer growth from within the blood coagulation mechanism.
    Zacharski LR
    J Thromb Haemost; 2011 Sep; 9(9):1804-6. PubMed ID: 21794073
    [No Abstract]   [Full Text] [Related]  

  • 37. [Research on the anti-"clearing factor" activity of human platelets].
    BALLERINI G; LA PAGLIA S
    Schweiz Med Wochenschr; 1961 Sep; 91():1141-3. PubMed ID: 13864438
    [No Abstract]   [Full Text] [Related]  

  • 38. [Inhibition of metastases by antithrombotic agents].
    Donati MB; Poggi A
    Internist (Berl); 1997 Jul; 38(7):644-9. PubMed ID: 9333597
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical evidence and rationale of mesoglycan to treat chronic venous disease and hemorrhoidal disease: a narrative review.
    Gallo G; Picciariello A; Tufano A; Camporese G
    Updates Surg; 2024 Apr; 76(2):423-434. PubMed ID: 38356039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1H-n.m.r. investigation of naturally occurring and chemically oversulphated dermatan sulphates. Identification of minor monosaccharide residues.
    Bossennec V; Petitou M; Perly B
    Biochem J; 1990 May; 267(3):625-30. PubMed ID: 2339978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.